Pharmacokinetics of Mitomycin C After Chemoembolization
Author Information
Author(s): Jin Wen Ding, Zai De Wu, Roland Andersson, Stig Bengmark
Primary Institution: Tongji Medical University, Wuhan, China; Lund University, Sweden
Hypothesis
Does gelfoam supplementation delay the clearance of mitomycin C from the liver?
Conclusion
Gelfoam does not significantly delay the clearance of mitomycin C from the liver.
Supporting Evidence
- The pharmacokinetics of mitomycin C were similar in both treatment groups.
- No significant differences in drug clearance were observed.
- Gelfoam did not prolong the drug's presence in the liver.
Takeaway
The study tested if a substance called gelfoam could help keep a cancer drug in the liver longer, but it found that it doesn't really help.
Methodology
Twelve mongrel dogs were divided into two groups to compare the pharmacokinetics of mitomycin C with and without gelfoam using blood sampling and high performance liquid chromatography.
Limitations
The study was conducted on a small sample size of dogs, which may not fully represent human responses.
Participant Demographics
Twelve mongrel dogs weighing 12-16 Kg.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website